Persistently misunderstood and malignant: the case of heart failure vs. cancer

被引：0
|
作者：
Stewart, Simon [1 ]
机构：
[1] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, NHMRC Ctr Res Excellence Hlth Serv Res Reduce Ine, Melbourne, Vic, Australia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2017年 / 19卷 / 09期
关键词：
DECADES; TRENDS;
D O I：
10.1002/ejhf.908
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1105 / 1106
页数：2
相关论文
共 50 条
  • [31] Clinical profile and management of heart failure: rural community hospital vs. metropolitan heart center
    Taubert, G
    Bergmeier, C
    Andresen, H
    Senges, J
    Potratz, J
    EUROPEAN JOURNAL OF HEART FAILURE, 2001, 3 (05) : 611 - 617
  • [32] Early vs. late worsening heart failure during acute heart failure hospitalization: insights from the PROTECT trial
    Mentz, Robert J.
    Metra, Marco
    Cotter, Gad
    Milo, Olga
    McKendry, Colleen
    Chiswell, Karen
    Davison, Beth A.
    Cleland, John G. F.
    Bloomfield, Daniel M.
    Dittrich, Howard C.
    Fiuzat, Mona
    Ponikowski, Piotr
    Givertz, Michael M.
    Voors, Adriaan A.
    Teerlink, John R.
    O'Connor, Christopher M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (07) : 697 - 706
  • [33] Autoimmunity vs. cancer: Predator vs. alien?
    Berens, Christian
    Lauber, Kirsten
    Herrmann, Martin
    AUTOIMMUNITY, 2013, 46 (05) : 287 - 293
  • [34] Lithium/thioridazineNeuroleptic malignant syndrome and heart failure: case report
    Reactions Weekly, 2003, 976 (1) : 13 - 13
  • [35] Living Well with Heart Failure: The Misnamed, Misunderstood Condition.
    Schneider, Janet M.
    LIBRARY JOURNAL, 2010, 135 (08) : 88 - 88
  • [36] HU FAILURE VS. VAD FAILURE: EFFICACY AND SAFETY OF TREATMENT CONCEPTS FOR TERMINAL HEART FAILURE IN THE CURRENT ERA
    Sunavsky, J.
    Schulz, U.
    Morshuis, M.
    Boergermann, J.
    Schoenbrodt, M.
    Hakim-Meibodi, K.
    Rehn, E.
    Eickmeyer, H.
    Fuchs, U.
    Gummert, J.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 33 - 33
  • [37] Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype
    Oatmen, Kelsie E.
    Cull, Elizabeth
    Spinale, Francis G.
    NATURE REVIEWS CARDIOLOGY, 2020, 17 (08) : 523 - 531
  • [38] Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype
    Kelsie E. Oatmen
    Elizabeth Cull
    Francis G. Spinale
    Nature Reviews Cardiology, 2020, 17 : 523 - 531
  • [39] Intermittent inotropic therapy with levosimendan vs. milrinone in advanced heart failure patients
    Milwidsky, Assi
    Frydman, Shir
    Laufer-Perl, Michal
    Sadeh, Ben
    Sapir, Orly
    Granot, Yoav
    Hochstadt, Aviram
    Korotetski, Liuba
    Ketchker, Liora
    Topilsky, Yan
    Banai, Shmuel
    Havakuk, Ofer
    ESC HEART FAILURE, 2022, 9 (02): : 1487 - 1491
  • [40] Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrate
    Delea, TE
    Stanford, R
    Hagiwara, M
    Edelsberg, JS
    Oster, G
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 99 (01) : 117 - 124
12345